Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesClonidine in Perioperative Medicine and Intensive Care Unit: More Than An Anti-Hypertensive Drug
Current Drug Targets, 09/03/09
Gregoretti C et al. – Clonidine used as a premedication drug before surgery or surgical procedure, has been shown to substantially reduce anaesthetic, benzodiazepine and opioids requirements. However, its “off label” use, the absence of an intravenous form of in the United States, possible inadvertent hypotension, bradycardia or post–operative sedation, and the variability of the haemodynamic response to different doses or rates of administration, have limited its use in clinical practice.
Related Articles
Clonidine versus Withdrawal Using an Opioid in In-Patient Opioid Detoxification
European Addiction Research, 11/16/09
Relevance Score: 87%
Influence of Clonidine on Bilateral Cervical Plexus Block using 0.25% Bupivacaine for Postoperative Analgesia following Thyroid Surgery
Journal of Anaesthesiology Clinical Pharmacology, 10/05/09
Relevance Score: 87%
A comparative study between bupivacaine and clonidine associated with bupivacaine in cervical plexus block for carotid endarterectomy
Revista Brasileira de Anestesiologia, 10/02/09
Relevance Score: 84%
Co-analgesics - today and tomorrow - A receptor-based overview of therapeutical options
Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS, 11/17/09
Relevance Score: 80%
Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery
Cochrane Reviews, 10/20/09
Relevance Score: 77%
Today in Cardiac/Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Inotrope and vasopressor use in the emergency department
Emergency Medicine Australasia, 12/10/09
Prediction of cardiovascular event risk reduction from lipid changes associated with high potency dyslipidemia therapy
Current Medical Research and Opinion, 12/10/09
Fyi from human genome sciences: gsk initiates second pivotal phase 3 trial for investigational cardiovascular medication darapladib
Human Genome Sciences, 12/10/09
Sponsor
Article Search
Sponsor
Sponsor